The assessment and management of infants with intrauterine drug exposure poses significant challenges to the clinician. These challenges can be met most appropriately by relying on accurate history taking of maternal drug use complemented by the use of standardized assessments of the drug-exposed neonate and reliance on proved protocols of pharmacologic and nonpharmacologic management.